Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/13/2005 | CN1638798A Antibody-containing solution pharmaceuticals |
07/13/2005 | CN1638793A Pharmaceutical and cosmetic compositions comprising PLGF-1 |
07/13/2005 | CN1638791A Stable pharmaceutical composition comprising erythropoietin |
07/13/2005 | CN1638789A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
07/13/2005 | CN1638780A Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
07/13/2005 | CN1638779A Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
07/13/2005 | CN1638773A Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient |
07/13/2005 | CN1638771A Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
07/13/2005 | CN1638769A Ophthalmic composition comprising ascomycin |
07/13/2005 | CN1638764A Eye drops containing tetrazole derivative |
07/13/2005 | CN1638760A Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
07/13/2005 | CN1638752A Pharmaceutical compositions |
07/13/2005 | CN1638749A Ambroxol for treating painful conditions in the mouth and pharyngeal cavity |
07/13/2005 | CN1638748A Taste-masked film-type or wafer-type medicinal preparation |
07/13/2005 | CN1638747A Sustained release pharmaceutical composition |
07/13/2005 | CN1638746A Colonic release composition |
07/13/2005 | CN1638745A Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
07/13/2005 | CN1638744A Production of starch-gel-based shaped bodies |
07/13/2005 | CN1638743A Implantable drug delivery system |
07/13/2005 | CN1638742A Sustained release preparations and process for producing the same |
07/13/2005 | CN1638741A Novel pharmaceutical dosage forms and method for producing same |
07/13/2005 | CN1638740A Modified release dosage forms |
07/13/2005 | CN1638739A Compound for treating assuetude disturbance |
07/13/2005 | CN1638738A Immediate release pharmaceutical granule compositions and a continuous process for making them |
07/13/2005 | CN1638737A Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
07/13/2005 | CN1638736A Composition and methods for treatment of hyperplasia |
07/13/2005 | CN1638735A Cubic liquid crystalline compositions and methods for their preparation |
07/13/2005 | CN1638734A Drug delivery system for the subconjunctival administration of fine grains |
07/13/2005 | CN1638732A Sustained release drug formulations containing a carrier peptide |
07/13/2005 | CN1638731A Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
07/13/2005 | CN1638730A Formoterol superfine formulation |
07/13/2005 | CN1638729A Pressurised metered dose inhalers containing solutions of beta-2 agonists |
07/13/2005 | CN1638728A Powder inhalation containing CGRP-antagonist BIBN4096 and method for the production thereof |
07/13/2005 | CN1638715A Granulation process |
07/13/2005 | CN1638632A Antimicrobial body covering articles |
07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636598A Methods to potentiate intravenous estramustine phosphate |
07/13/2005 | CN1636595A An EPI-HNE protein dry powder |
07/13/2005 | CN1636592A Stabilized liquid polypeptide-containing pharmaceutical composition |
07/13/2005 | CN1636591A Stabilized pharmaceutical composition in lyophilized form |
07/13/2005 | CN1636589A Non-aqueous polar aprotic peptide formulations |
07/13/2005 | CN1636588A Red yeast prepn containing active components of glossy ganoderma and its prepn process |
07/13/2005 | CN1636583A Medicine composition for treating women's pulvic infection and its prepn process and use |
07/13/2005 | CN1636582A Medicated bra for treating mastoproliferation |
07/13/2005 | CN1636581A Safflower medicine composition and its prepn process and use |
07/13/2005 | CN1636580A Medicine composition for treating coronary heart disease and its prepn process and use |
07/13/2005 | CN1636579A Hypoglycemic Chinese medicine prepn and its production process |
07/13/2005 | CN1636577A Vaginal care composition |
07/13/2005 | CN1636576A Application of bioactive glass in preparing medicine for treating gastroduodenal ulcer |
07/13/2005 | CN1636575A Application of CMC grafted polyacrylic acid in preparing hemostatic and hemostatic material |
07/13/2005 | CN1636573A Vitamin-medicine composition and its use |
07/13/2005 | CN1636567A Piperazine derivative used as CCRS antagonist |
07/13/2005 | CN1636564A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
07/13/2005 | CN1636561A Use of at-1 receptor antagonist for treating diseases associated with an increase of at-1 receptors |
07/13/2005 | CN1636560A Injectable taxane derivative based compositions |
07/13/2005 | CN1636558A Tablet containing brufen and producing process thereof |
07/13/2005 | CN1636555A Transdermal drug delivery matrix for coadministering estradiol and another steroid |
07/13/2005 | CN1636554A Process for producing soft gelatin capsule |
07/13/2005 | CN1636553A Volatile proof solid preparation and producing method thereof |
07/13/2005 | CN1636552A Ascending-dose dosage form |
07/13/2005 | CN1636551A Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
07/13/2005 | CN1636550A Water-in-oil emulsion composition |
07/13/2005 | CN1636549A Oil-in-water emulsion composition |
07/13/2005 | CN1636548A Product for administration of active agents to different areas of the skin |
07/13/2005 | CN1636546A Sprayable skin protectant compositions |
07/13/2005 | CN1210290C Delivery of nucleic acids |
07/13/2005 | CN1210281C Titanium derived compounds, rpeparation an use thereof |
07/13/2005 | CN1210258C Glyburide composition |
07/13/2005 | CN1210190C Injection molded water soluble container |
07/13/2005 | CN1210080C Assembly for local administration of solid and semisolid pharmaceutical and use thereof |
07/13/2005 | CN1210079C Preparation for vaginal ring and its application |
07/13/2005 | CN1210065C Solid dispersion system with Pranlukast for improving dissolution, and the preparing method thereof |
07/13/2005 | CN1210063C Complex local medicine for mainly treating oral ulcer |
07/13/2005 | CN1210058C Stable concentrated insulin preparations for pulmonary delivery |
07/13/2005 | CN1210057C Blood lipid capsule and its preparing method |
07/13/2005 | CN1210056C Method for preparing Chinese medicinal tablet by ultramicropulverization technology |
07/13/2005 | CN1210054C Novel preparation method for ageratum zhengqi capsule |
07/13/2005 | CN1210053C Immunologic function excitant for treating AIDS |
07/13/2005 | CN1210048C Gingko leaf drop pill |
07/13/2005 | CN1210041C Complex external medicine for treating acne |
07/13/2005 | CN1210040C Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease |
07/13/2005 | CN1210035C Complex external medicine for treating psoriasis |
07/13/2005 | CN1210032C Parenteral formulations comprising carbamazepine or its derivatives |
07/13/2005 | CN1210031C Injectable slow-releasing naltrexone microsphere compositions |
07/13/2005 | CN1210028C Aqueous liquid preparation |
07/13/2005 | CN1210026C Melatonin two-layer release-controlled tablet and preparing process thereof |
07/13/2005 | CN1210025C Tanshinone compound containing dihydrofuran ring structure for curing hyperammonemia and hepatic encephalopathy |
07/13/2005 | CN1210024C Crytotanshinone for preventing and delaying early senile dementia |
07/13/2005 | CN1210023C Carboplatin precursor liposome injection and preparing process thereof |
07/13/2005 | CN1210022C Dichlofenac sodium slow-releasing preparation and its preparation method |
07/13/2005 | CN1210021C Novel formulation for counteracting ethylene response in plants ,preparation process thereof and method using the same |
07/13/2005 | CN1210020C Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma |
07/13/2005 | CN1210019C II type collagen water soluble dispersion composition, its preparation method and application |
07/13/2005 | CN1210018C Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and speed of dissolution |
07/13/2005 | CN1210017C Novel tiotropiumonium-containing inhalation powder |
07/13/2005 | CN1210007C Disposable thermal body wrap |
07/12/2005 | US6916958 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions |